ストックスクリーナーアプリを入手
41.85
11.47%
-5.42
アフターアワーズ：
42.61
0.76
+1.82%
Axogen Inc (AXGN) 最新ニュース
Why Is Axogen Stock Tumbling Today?Axogen (NASDAQ:AXGN) - Benzinga
Axogen to buy BioCircuit Technologies for $200M - MedTech Dive
2 Medical-Device Stocks Lighting Up the Options Pits - Schaeffer's Investment Research
Axogen stock falls as $208.7M offering dilutes shareholders - Investing.com
Axogen Prices $208.7 Million Stock Offering to Fund BioCircuit Acquisition - citybiz
Axogen to Acquire BioCircuit Technologies in $200 Million Nerve Repair Deal - citybiz
Why is Axogen stock sliding today? By Investing.com - Investing.com Canada
Why is Axogen stock sliding today? - Investing.com
Axogen acquires BioCircuit Technologies for $200 million - grafa.com
Axogen Announces Pricing Of $208.7 Million Public Offering Of Common Stock - TradingView
AxoGen to Acquire BioCircuit, Expanding Nerve Repair Portfolio - TipRanks
Axogen prices $208.7 million stock offering at $42.50 per share - Investing.com
AXGN Looks 171.8% Overvalued on GF Value™ - GuruFocus
Form 8K Axogen Inc For: 10 September By Investing.com - Investing.com Canada
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock - The Manila Times
Axogen prices $208.7 million stock offering at $42.50 per share By Investing.com - Investing.com Canada
Axogen Prices $208.7 Million Public Offering of Common Stock to Help Fund BioCircuit Acquisition - Quiver Quantitative
AXGN: Acquisition of a pioneering sutureless nerve repair device is expected to drive growth and innovation - TradingView
Axogen to acquire BioCircuit for $200M, adds nerve repair device - Investing.com UK
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies - GlobeNewswire
Understanding the Setup: (AXGN) and Scalable Risk - Stock Traders Daily
Axogen Director Tyndall Joseph A. Disposes of 3,500 Shares at $49.70 Each - Kalkine Media
Axogen (AXGN) Director Joseph Tyndall Sells 3,500 Shares - GuruFocus
Axogen Inc (AXGN) Shares Fall 3.2% -- What GF Score of 64 Tells Investors - GuruFocus
Axogen (NASDAQ: AXGN) director plans $174K stock sale - stocktitan.net
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference - Yahoo Finance
Axogen stock hits 52-week high at 51.13 USD By Investing.com - Investing.com South Africa
Axogen Inc (AXGN) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 64/100 - GuruFocus
Truist initiates AxoGen stock with buy rating on growth potential By Investing.com - Investing.com Canada
Truist Financial Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $60 - Moomoo
Axogen (AXGN) Close: Ends Lower by 2.32% at $49.23 in the Latest Reading; Immediate View - vinanet.vn
AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates - Eastern Progress
Axogen (AXGN) Price: Adds 8.53% to Close at $50.40 in the Latest Session; Market Levels: Price Remains Between $47.88 Support and $52.92 Resistance on the DayMedian Line - siam.in
Axogen Inc (AXGN) Shares Surge 8.5% -- What GF Score of 66 Tells Investors - GuruFocus
Axogen Inc (NASDAQ: AXGN) Share Price, AXGN Stock News, AXGN Share Price & Updates - kalkine.ca
Price to sales ratio of Axogen, Inc. – BMV:AXGN - TradingView
31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A. - MarketBeat
Price to sales ratio of Axogen, Inc. – BIVA:AXGN - TradingView
Taxes of Axogen, Inc. – BMV:AXGN - TradingView
ETFs Investing in Axogen, Inc. Stocks - TradingView
AXGN Stock Price and Chart — BIVA:AXGN - TradingView
Cash per share of Axogen, Inc. – BMV:AXGN - TradingView
Axogen, Inc. Cash Flow – BIVA:AXGN - TradingView
Axogen, Inc. Statistics – BMV:AXGN - TradingView
Lisanti Capital Growth LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
Tocqueville Asset Management L.P. Takes $8.03 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 52-Week HighHere's Why - MarketBeat
Axogen stock reaches 52-week high at 50.0 USD By Investing.com - Investing.com Canada
Axogen stock reaches 52-week high at 50.0 USD - Investing.com
Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN - MarketBeat
689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC - MarketBeat
Axogen director Amy Wendell sells $646k in shares By Investing.com - Investing.com Australia
Axogen director Amy Wendell sells $646k in shares - Investing.com
First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens - Stock Titan
Axogen (AXGN) Q2 2026 Earnings Call Transcript - AOL.com
Axogen EVP Marc Began Executes Stock Option Exercise and Sells Shares Under 10b5-1 Plan - Kalkine Media
Axogen Director Amy McBride-Wendell Executes and Sells 13,353 Shares Under 10b5-1 Plan - Kalkine Media
AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock - MarketBeat
Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing - marketscreener.com
Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing - marketscreener.com
2.29%
0.75%
大文字化:
|
ボリューム (24 時間):